Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Cancer Analytics Company Acquired in $1.9B Deal

The global pharmaceutical company Roche is purchasing the cancer data management and analytics enterprise Flatiron Health in New York for $1.9 billion. . . . → Read More: Cancer Analytics Company Acquired in $1.9B Deal

FDA Clears First Blood Test for Concussions

The Food and Drug Administration authorized for marketing in the U.S. a blood test that screens for chemical indicators in the blood for concussions, a form of traumatic brain injury. . . . → Read More: FDA Clears First Blood Test for Concussions

Report – Industry Pain, Addiction Drug Efforts Flagging

A report by a biotechnology industry organization says development efforts and financing for new drugs to treat pain and addiction are falling behind the health and safety needs of society. . . . → Read More: Report – Industry Pain, Addiction Drug Efforts Flagging

FDA Approves Wearable Epilepsy Seizure Detector

The U.S. Food and Drug Administration approved a device worn like a wristwatch that uses a machine-learning algorithm to detect convulsive seizures in people with epilepsy. . . . → Read More: FDA Approves Wearable Epilepsy Seizure Detector

Report: 19 New Precision Medicines Approved in 2017

A report on Food and Drug Administration approvals of new therapies says the agency is accelerating its reviews of treatments designed to address the specific molecular composition of individuals. . . . → Read More: Report: 19 New Precision Medicines Approved in 2017

Spin-Off Gains FDA Clearance for Bone Graft Material

A company spun-off from a university tissue engineering research lab received clearance from the Food and Drug Administration to market its polymer material in the U.S. to help regrow bones. . . . → Read More: Spin-Off Gains FDA Clearance for Bone Graft Material

Agencies Send Warnings to Halt Opioid Cessation Scams

Two federal agencies sent warning letters to companies the agencies say are illegally marketing products making false or unsubstantiated claims about their treating opioid addiction or withdrawal. . . . → Read More: Agencies Send Warnings to Halt Opioid Cessation Scams

FDA to Release More Accessible Clinical Trial Data

The U.S. Food and Drug Administration plans to make available in a more user-friendly format details from clinical trials of new drugs approved by the agency. . . . → Read More: FDA to Release More Accessible Clinical Trial Data

FDA Clears Targeted Breast Cancer Radiation Treatment

The U.S. Food and Drug Administration approved a device that sends high doses of radiation to cancerous breast tissue while sparing healthy tissue nearby. . . . → Read More: FDA Clears Targeted Breast Cancer Radiation Treatment

FDA Approves Gene Therapy for Inherited Vision Loss

A therapy using transfers of healthy genes to treat a rare form of inherited vision loss was approved today by the U.S. Food and Drug Administration. . . . → Read More: FDA Approves Gene Therapy for Inherited Vision Loss